Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Vaccines

Free Subscription 29.11.2021 3 Ann Intern Med 6 BMJ 1 Infect Immun 1 J Infect 4 J Virol 6 JAMA 2 Lancet 1 MMWR Morb Mortal Wkly Rep 1 N Engl J Med 1 Nat Immunol 1 Nat Med 3 Pediatrics 6 PLoS One 1 Science 21 Vaccine

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Intern Med

1. KUMAR D, Ferreira VH, Hall VG, Hu Q, et al
   Neutralization of SARS-CoV-2 Variants in Transplant Recipients After Two and Three Doses of mRNA-1273 Vaccine : Secondary Analysis of a Randomized Trial.
   Ann Intern Med. 2021 Nov 23. doi: 10.7326/M21-3480.
   PubMed         Abstract available
   
   
2. MOGHADAS SM, Sah P, Shoukat A, Meyers LA, et al
   Population Immunity Against COVID-19 in the United States.
   Ann Intern Med. 2021 Sep 14. doi: 10.7326/M21-2721.
   PubMed         Abstract available
   
   
3. PALTIEL AD, Schwartz JL
   Assessing COVID-19 Prevention Strategies to Permit the Safe Opening of Residential Colleges in Fall 2021.
   Ann Intern Med. 2021 Aug 31. doi: 10.7326/M21-2965.
   PubMed         Abstract available
   
   

   
   BMJ

4. ISRAEL A, Merzon E, Schaffer AA, Shenhar Y, et al
   Elapsed time since BNT162b2 vaccine and risk of SARS-CoV-2 infection: test negative design study.
   BMJ. 2021;375:e067873.
   PubMed         Abstract available
   
   
5. EXTANCE A
   mRNA vaccines: hope beneath the hype.
   BMJ. 2021;375:n2744.
   PubMed        
   
   
6. MAHASE E
   Covid-19: What next for the Valneva vaccine?
   BMJ. 2021;375:n2839.
   PubMed        
   
   
7. IACOBUCCI G
   Covid-19 and pregnancy: vaccine hesitancy and how to overcome it.
   BMJ. 2021;375:n2862.
   PubMed        
   
   
8. ALTMANN D, Boyton R
   Covid-19 caseload in the UK-assessments and mitigations.
   BMJ. 2021;375:n2843.
   PubMed        
   
   
9. TALIC S, Shah S, Wild H, Gasevic D, et al
   Effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality: systematic review and meta-analysis.
   BMJ. 2021;375:e068302.
   PubMed         Abstract available
   
   

   
   Infect Immun

10. LI P, Wang X, Sun X, Cimino J, et al
    Recombinant Pseudomonas Bionanoparticles Induce Protection against Pneumonic Pseudomonas aeruginosa Infection.
    Infect Immun. 2021;89:e0039621.
    PubMed         Abstract available
    
    

    
    J Infect

11. LEBOURGEOIS S, Menidjel R, Chenane HR, Ferre VM, et al
    Alpha (B.1.1.7) and Delta (B.1.617.2 - AY.40) SARS-CoV-2 variants present strong neutralization decay at M4 post-vaccination and a faster replication rates than D614G (B.1) lineage.
    J Infect. 2021 Nov 19. pii: S0163-4453(21)00556.
    PubMed        
    
    

    
    J Virol

12. WU C, He Y, Zhao J, Luo K, et al
    Exacerbated AIDS progression by PD-1 blockade during therapeutic vaccination in chronically SIV-infected rhesus macaques after ART treatment interruption.
    J Virol. 2021 Nov 24:JVI0178521. doi: 10.1128/JVI.01785.
    PubMed         Abstract available
    
    
13. APPELBERG S, John L, Pardi N, Vegvari A, et al
    Nucleoside-modified mRNA vaccines protect IFNAR(-/-) mice against Crimean Congo hemorrhagic fever virus infection.
    J Virol. 2021 Nov 24:JVI0156821. doi: 10.1128/JVI.01568.
    PubMed         Abstract available
    
    
14. BURCKHARDT RM, Dennehy JJ, Poon LLM, Saif LJ, et al
    Are COVID-19 Vaccine Boosters Needed? The Science behind Boosters.
    J Virol. 2021 Nov 24:JVI0197321. doi: 10.1128/JVI.01973.
    PubMed         Abstract available
    
    
15. ZHANG H, Zheng H, Guo P, Hu L, et al
    Correction for Zhang et al., "Broadly Protective CD8(+) T Cell Immunity to Highly Conserved Epitopes Elicited by Heat Shock Protein gp96-Adjuvanted Influenza Monovalent Split Vaccine".
    J Virol. 2021;95:e0175021.
    PubMed        
    
    

    
    JAMA

16. ABBASI J
    The Flawed Science of Antibody Testing for SARS-CoV-2 Immunity.
    JAMA. 2021 Oct 21. pii: 2785530. doi: 10.1001/jama.2021.18919.
    PubMed        
    
    
17. JABAGI MJ, Botton J, Bertrand M, Weill A, et al
    Myocardial Infarction, Stroke, and Pulmonary Embolism After BNT162b2 mRNA COVID-19 Vaccine in People Aged 75 Years or Older.
    JAMA. 2021 Nov 22. pii: 2786667. doi: 10.1001/jama.2021.21699.
    PubMed        
    
    
18. KUEHN BM
    Unhygienic Practices Lead to Routine Vaccination-Linked Infections.
    JAMA. 2021;326:2002.
    PubMed        
    
    
19. KUEHN BM
    COVID-19 Vaccine Highly Effective Against Adolescent Hospitalizations.
    JAMA. 2021;326:2002.
    PubMed        
    
    
20. RUBIN R
    Substance Use Disorders and COVID-19 Vaccine Response.
    JAMA. 2021;326:2000.
    PubMed        
    
    
21. RUBIN R
    COVID-19 Vaccine Makers Plan for Annual Boosters, but It's Not Clear They'll Be Needed.
    JAMA. 2021 Nov 24. pii: 2786818. doi: 10.1001/jama.2021.21291.
    PubMed        
    
    

    
    Lancet

22. JAFFE S
    Legal challenges threaten Biden's COVID-19 vaccine rule.
    Lancet. 2021;398:1863-1864.
    PubMed        
    
    
23. DEVI S
    Health in Syria: a decade of conflict.
    Lancet. 2021;397:955-956.
    PubMed        
    
    

    
    MMWR Morb Mortal Wkly Rep

24. SHAH MM, Perez A, Lively JY, Avadhanula V, et al
    Enterovirus D68-Associated Acute Respiratory Illness horizontal line New Vaccine Surveillance Network, United States, July-November 2018-2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:1623-1628.
    PubMed         Abstract available
    
    

    
    N Engl J Med

25. MURPHY WJ, Longo DL
    A Possible Role for Anti-idiotype Antibodies in SARS-CoV-2 Infection and Vaccination.
    N Engl J Med. 2021 Nov 24. doi: 10.1056/NEJMcibr2113694.
    PubMed        
    
    

    
    Nat Immunol

26. IRVINE EB, O'Neil A, Darrah PA, Shin S, et al
    Robust IgM responses following intravenous vaccination with Bacille Calmette-Guerin associate with prevention of Mycobacterium tuberculosis infection in macaques.
    Nat Immunol. 2021 Nov 22. pii: 10.1038/s41590-021-01066.
    PubMed         Abstract available
    
    

    
    Nat Med

27. O'LEARY K
    An mRNA vaccine against tick bites.
    Nat Med. 2021 Nov 25. pii: 10.1038/d41591-021-00071.
    PubMed        
    
    

    
    Pediatrics

28. VAN DONGEN JAP, Rouers EDM, Schuurman R, Band C, et al
    Rotavirus Vaccine Safety and Effectiveness in Infants With High-Risk Medical Conditions.
    Pediatrics. 2021 Nov 22. pii: 183442. doi: 10.1542/peds.2021-051901.
    PubMed         Abstract available
    
    
29. GROSE C
    From King Nebuchadnezzar of Babylon to Mumps Genotyping and Vaccination 26 Centuries Later.
    Pediatrics. 2021 Nov 22. pii: 183432. doi: 10.1542/peds.2021-052761.
    PubMed        
    
    
30. SHEPERSKY L, Marin M, Zhang J, Pham H, et al
    Mumps in Vaccinated Children and Adolescents: 2007-2019.
    Pediatrics. 2021 Nov 22. pii: 183441. doi: 10.1542/peds.2021-051873.
    PubMed         Abstract available
    
    

    
    PLoS One

31. ZORIGT T, Furuta Y, Simbotwe M, Ochi A, et al
    Development of ELISA based on Bacillus anthracis capsule biosynthesis protein CapA for naturally acquired antibodies against anthrax.
    PLoS One. 2021;16:e0258317.
    PubMed         Abstract available
    
    
32. YAMAMOTO K, Suzuki M, Ujiie M, Kanagawa S, et al
    Catch-up immunization for adolescents and young adults during pre-travel consultation in Japan.
    PLoS One. 2021;16:e0258357.
    PubMed         Abstract available
    
    
33. DEVI YD, Goswami HB, Konwar S, Doley C, et al
    Immunoinformatics mapping of potential epitopes in SARS-CoV-2 structural proteins.
    PLoS One. 2021;16:e0258645.
    PubMed         Abstract available
    
    
34. CHACON-DIAZ C, Zabalza-Barangua A, San Roman B, Blasco JM, et al
    Brucella abortus S19 GFP-tagged vaccine allows the serological identification of vaccinated cattle.
    PLoS One. 2021;16:e0260288.
    PubMed         Abstract available
    
    
35. VAN EGEREN D, Stoddard M, Novokhodko A, Rogers MS, et al
    Rapid relaxation of pandemic restrictions after vaccine rollout favors growth of SARS-CoV-2 variants: A model-based analysis.
    PLoS One. 2021;16:e0258997.
    PubMed         Abstract available
    
    
36. PHATIHATTAKORN C, Wongsa A, Pongpan K, Anuwuthinawin S, et al
    Seroprevalence of Zika virus in pregnant women from central Thailand.
    PLoS One. 2021;16:e0257205.
    PubMed         Abstract available
    
    

    
    Science

37. GILBERT PB, Montefiori DC, McDermott AB, Fong Y, et al
    Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial.
    Science. 2021 Nov 23:eab3435.
    PubMed         Abstract available
    
    

    
    Vaccine

38. HARA M, Koshida R, Nakano T
    Parents' views on mumps, mumps vaccine, and the factors associated with vaccination in Japan.
    Vaccine. 2021 Nov 20. pii: S0264-410X(21)01449.
    PubMed         Abstract available
    
    
39. HOFF NA, Bratcher A, Mukadi P, Ahuka S, et al
    Increasing Ebola transmission behaviors 6 months post-vaccination: Comparing vaccinated and unvaccinated populations near 2018 Mbandaka Ebola outbreak in the Democratic Republic of Congo.
    Vaccine. 2021 Nov 16. pii: S0264-410X(21)01404.
    PubMed         Abstract available
    
    
40. VOSS G, Jacquet JM, Tornieporth N, Kampmann B, et al
    Meeting report: CEPI consultation on accelerating access to novel vaccines against emerging infectious diseases for pregnant and lactating women, London, 12-13 February 2020.
    Vaccine. 2021 Nov 16. pii: S0264-410X(21)01382.
    PubMed         Abstract available
    
    
41. VOHRA P, Chintoan-Uta C, Bremner A, Mauri M, et al
    Evaluation of a Campylobacter jejuni N-glycan-ExoA glycoconjugate vaccine to reduce C. jejuni colonisation in chickens.
    Vaccine. 2021 Nov 16. pii: S0264-410X(21)01434.
    PubMed         Abstract available
    
    
42. KITRO A, Sirikul W, Piankusol C, Rirermsoonthorn P, et al
    Acceptance, attitude, and factors affecting the intention to accept COVID-19 vaccine among Thai people and expatriates living in Thailand.
    Vaccine. 2021 Nov 17. pii: S0264-410X(21)01476.
    PubMed         Abstract available
    
    
43. BELLIZZI S, Aidyralieva C, Al-Shaikh A, Muthu N, et al
    Inclusiveness of prisons in COVID-19 vaccination deployment: Evidence from Jordan.
    Vaccine. 2021 Nov 18. pii: S0264-410X(21)01468.
    PubMed        
    
    
44. SUN P, Jani V, Johnson A, Cheng Y, et al
    T cell and memory B cell responses in tetravalent DNA, tetravalent inactivated and tetravalent live-attenuated prime-boost dengue vaccines in rhesus macaques.
    Vaccine. 2021 Nov 22. pii: S0264-410X(21)01325.
    PubMed         Abstract available
    
    
45. BETTENCOURT PJG, Joosten SA, Lindestam Arlehamn CS, Behr MA, et al
    100 years of the Bacillus Calmette-Guerin vaccine.
    Vaccine. 2021 Nov 22. pii: S0264-410X(21)01483.
    PubMed        
    
    
46. MARTIN S, Vanderslott S
    "Any idea how fast 'It's just a mask!' can turn into 'It's just a vaccine!'": From mask mandates to vaccine mandates during the COVID-19 pandemic.
    Vaccine. 2021 Oct 28. pii: S0264-410X(21)01351.
    PubMed         Abstract available
    
    
47. WANG W, Wang Y, Wang Y, Yan F, et al
    Vaccine bidding, procurement and distribution management practices in mainland China: A nationwide study.
    Vaccine. 2021 Nov 18. pii: S0264-410X(21)01465.
    PubMed         Abstract available
    
    
48. BLAIN AE, Reese HE, Marjuki H, Topaz N, et al
    Serogroup A, C, W, and Y meningococcal disease in persons previously vaccinated with a serogroup ACWY meningococcal vaccine - United States, 2014-2018.
    Vaccine. 2021 Nov 18. pii: S0264-410X(21)01480.
    PubMed         Abstract available
    
    
49. YE K, Shi D, Zhang Z, Bian L, et al
    A chemiluminescence immunoassay for precise automatic quality control of glycoprotein in human rabies vaccine.
    Vaccine. 2021 Nov 20. pii: S0264-410X(21)01393.
    PubMed         Abstract available
    
    
50. WU K, Choi A, Koch M, Elbashir S, et al
    Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in mice.
    Vaccine. 2021 Nov 8. pii: S0264-410X(21)01435.
    PubMed         Abstract available
    
    
51. LAU CL, Mayfield HJ, Sinclair JE, Brown SJ, et al
    Risk-benefit analysis of the AstraZeneca COVID-19 vaccine in Australia using a Bayesian network modelling framework.
    Vaccine. 2021 Nov 4. pii: S0264-410X(21)01428.
    PubMed         Abstract available
    
    
52. VIZCARRA P, Haemmerle J, Velasco H, Velasco T, et al
    BNT162b2 mRNA COVID-19 vaccine Reactogenicity: The key role of immunity.
    Vaccine. 2021 Nov 11. pii: S0264-410X(21)01417.
    PubMed         Abstract available
    
    
53. ORTEGA-SANCHEZ IR, Mott JA, Kittikraisak W, Khanthamaly V, et al
    Cost-effectiveness of seasonal influenza vaccination in pregnant women, healthcare workers and adults >= 60 years of age in Lao People's Democratic Republic.
    Vaccine. 2021 Nov 18. pii: S0264-410X(21)01445.
    PubMed         Abstract available
    
    
54. IRVING SA, Ball SW, Booth SM, Regan AK, et al
    A multi-country investigation of influenza vaccine coverage in pregnant individuals, 2010-2016.
    Vaccine. 2021 Nov 18. pii: S0264-410X(21)01463.
    PubMed         Abstract available
    
    
55. AREGA SM, Knobel DL, Toka FN, Conan A, et al
    Non-specific effects of veterinary vaccines: a systematic review.
    Vaccine. 2021 Nov 20. pii: S0264-410X(21)01479.
    PubMed         Abstract available
    
    
56. SILAS J, Jones A, Weiss-Cohen L, Ayton P, et al
    The seductive allure of technical language and its effect on covid-19 vaccine beliefs and intentions.
    Vaccine. 2021 Nov 15. pii: S0264-410X(21)01472.
    PubMed         Abstract available
    
    
57. ROSENTHAL S, Cummings CL
    Influence of rapid COVID-19 vaccine development on vaccine hesitancy.
    Vaccine. 2021 Nov 13. pii: S0264-410X(21)01448.
    PubMed         Abstract available
    
    
58. HAFNER-GIESSAUF H, Horn S, Schwantzer G, Sprenger-Mahr H, et al
    Cholecalciferol supplementation to improve the hepatitis B vaccination response in hemodialysis patients: A first randomized open label pilot study (DeVitaHep).
    Vaccine. 2021 Nov 18. pii: S0264-410X(21)01474.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: